The global probiotics market is projected to grow significantly, with its size expected to reach USD 131 billion by 2032 from USD 62.4 billion in 2022, representing a compound annual growth rate (CAGR) of 7.9% during the forecast period from 2022 to 2032. This growth is driven by increasing consumer awareness about the health benefits of probiotics, including improved digestive health, enhanced immune function, and potential mental health benefits. The rising prevalence of gastrointestinal disorders and the growing popularity of functional foods and dietary supplements are also contributing to market expansion.
Recent developments in the market include innovations in probiotic strains and delivery methods, as well as strategic partnerships aimed at expanding market reach. For instance, BioGaia launched a new probiotic product to support children’s respiratory health, and AB-Biotics formed a strategic partnership with AceBiome to increase the availability of their probiotics in South Korea.
Challenges in the probiotics market include the lack of standardized regulations, which can lead to variations in product quality and efficacy, and the sensitivity of probiotic microorganisms to environmental conditions, affecting product stability. Additionally, high research and development costs and safety concerns for certain populations pose significant hurdles.
Overall, the probiotics market is poised for robust growth, supported by increasing health consciousness, innovative product development, and expanding applications in both human and animal health.
Key Takeaways
- The global probiotics market is expected to reach USD 131.0 billion by 2032, growing at a CAGR of 7.9%.
- Probiotics are beneficial microorganisms that enhance gut health, support the immune system, and treat diseases like mental illnesses, digestive problems, and neurological disorders.
- Market expansion is driven by increasing health awareness and demand for natural products.
- Rising health concerns and digestive issues boost the consumption of probiotics.
- Advancements in distribution channels, especially supermarkets and online retail, contribute significantly to market growth.
- The risk of contamination of probiotic products by harmful microbes is a market restraint.
- High R&D investment is necessary for developing new probiotic bacteria strains.
- Bacteria like lactobacilli, bifidobacterium, and streptococcus dominate the probiotics market due to their health benefits.
- Yeast, particularly saccharomyces boulardii, also plays a significant role in market growth.
- Preventative healthcare is the dominant function of probiotics, focusing on enhancing intestinal health and reducing disease risk.
- Dietary supplements hold the largest market share, followed by food and beverages, and animal feed.
- The growing popularity of natural and healthy foods drives the consumption of probiotics.
- Supermarkets and hypermarkets are the dominant distribution channels, with online retail gaining popularity for its convenience.
- Probiotics are primarily used for human consumption due to rising health concerns and preference for natural foods.
- Probiotics are also used in animal feed to promote digestion and treat animal-related diseases.
- The increasing use of probiotics in food and beverages presents lucrative growth opportunities, especially in emerging economies.
- Manufacturers focus on product innovation and differentiation due to the competitive landscape.
- Market consolidation is observed through mergers, acquisitions, and partnerships among key players.
- Asia Pacific leads the global probiotics market, with strong demand in emerging countries like China and India.
- North America benefits from advanced R&D facilities and high technological adoption in the probiotics market.
- Key players in the probiotics market include BioGaia AB, Danone S.A., PepsiCo Inc., CHR Hansen, Yakult Honsha Co., Ltd., and Nestle SA.
Get Sample PDF Report: https://market.us/report/probiotics-market/request-sample/
Probiotic Market Key Segments
Based on Ingredient
- Bacteria
- Yeast
Based on Function
- Regular
- Preventative Healthcare
- Therapeutic
Based on Application
- Food & Beverage
- Dietary Supplement
- Animal Feed
Based on Distribution Channel
- Supermarkets/Hypermarkets
- Pharmacies/Health Stores
- Convenience Stores
- Online Retail
Based on End-Use
- Human
- Animal
Key Regions
- North America (The US, Canada, Mexico)
- Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
- Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
- APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Buy Directly: https://market.us/purchase-report/?report_id=18060
Key Players Analysis
BioGaia AB is a Swedish company specializing in probiotics, particularly the lactic acid bacterium Limosilactobacillus reuteri. The company develops, markets, and sells probiotic products that benefit gut, oral, and immune health. Their operations are divided into segments for pediatric and adult health, with products like gut health tablets, oral health lozenges, and oral rehydration solutions. BioGaia’s strong presence in the Asia Pacific and EMEA regions has driven significant sales growth. The company’s strategy focuses on growing its core product portfolio, expanding direct markets, and breakthrough innovations in probiotics.
Lallemand Inc. is a Canadian company that manufactures and markets high-quality yeast, bacteria, and specialty ingredients. In the probiotic sector, Lallemand focuses on providing solutions for human health, animal nutrition, and bio-ingredients. Their extensive research and development efforts ensure the efficacy and safety of their probiotic strains. Lallemand’s probiotics are used globally, and the company continues to innovate in areas such as gut health, immune support, and mental health, contributing significantly to the global probiotic market.
Lifeway Foods Inc. is an American company known for its kefir products, a type of probiotic-rich fermented milk drink. Founded in 1986, Lifeway has expanded its product line to include a variety of kefir flavors, as well as organic, non-fat, and whole milk options. The company emphasizes the health benefits of probiotics, such as improved digestion and immune function. Lifeway’s products are widely available across the United States, and the company continues to grow by focusing on health trends and consumer demand for functional foods.
Danone S.A. is a French multinational food-products corporation and a leader in the probiotic sector. The company offers a range of probiotic dairy products, including yogurts and fermented milk drinks under brands like Activia and Actimel. Danone invests heavily in research and development to support the health benefits of its probiotic strains. Their products aim to improve digestive health and overall well-being. Danone’s global reach and strong brand presence make it a significant player in the probiotic market, continually expanding into new markets and product categories.
PepsiCo Inc., a global food and beverage giant, has ventured into the probiotic market with its Tropicana Essentials Probiotics line. This product range includes juices fortified with probiotics to support digestive health. PepsiCo leverages its extensive distribution network and marketing expertise to promote these health-oriented products. By incorporating probiotics into popular consumer goods, PepsiCo aims to meet the growing demand for functional beverages that offer added health benefits, positioning itself as a competitive force in the probiotic sector.
Probiotic Market Key Players:
- BioGaia AB
- Lallemand Inc.
- Lifeway Foods Inc.
- Danone S.A.
- PepsiCo Inc.
- Arla Foods Inc.
- Morinaga Milk Industry Co. Ltd
- CHR Hansen
- Hansen Holding A/S
- Yakult Honsha Co. Ltd.
- Probi AB
- Lifeway Foods Inc.
- Nestle SA
- Ganeden Inc.
- Kerry Inc.
- Post Holdings Inc.
- Pepsico Inc.
- Evolve Biosystems Inc.
Probiotic Market Report Scope >> Market Value (2022): USD 62.4 Billion || Forecast Revenue (2032): USD 131 Billion || CAGR (2023-2032): 7.9% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.
Inquire More about report: https://market.us/report/probiotics-market/#inquiry
About Market.US
Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.
Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: [email protected]
Blog: https://medicalmarketreport.com/
View More Trending Reports
Medical 3D Printing Market Projected to reach USD 4593.7 Mn with 19.5% CAGR By 2033
Medical Camera Market Estimated to Reach USD 6.4 Billion by 2033
Cimzia (certolizumab) Drug Market Poised to Reach USD 7.3 Billion by 2033
Veterinary Surgical Instruments Market Expected to Attain USD 2.2 Billion by 2033
Glucagon Market Sees Surge, Reaches USD 1102.2 Mn Value by 2033